{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:47:49Z","timestamp":1783532869888,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Lipoprotein glomerulopathy is a rare kidney disease characterized by lipoprotein thrombi in the glomerulus. Here, we report a case of lipoprotein glomerulopathy in a Chinese pediatric patient. Furthermore, we summarized the clinical features and genetic characteristics of lipoprotein glomerulopathy in China.<\/jats:p><jats:p><jats:bold>Case Presentation:<\/jats:bold> An 11-year-old Chinese girl presented with nephrotic syndrome with anemia (98 g\/L). After excluding secondary causes, primary nephrotic syndrome was considered. Treatment with prednisone (60 mg\/day) did not improve her condition. Renal biopsy showed marked dilation of the capillary lumen with lipoprotein thrombi and positive oil red O staining. Genetic testing revealed the genetic variant c.127C &amp;gt; T (p.R43C), known as the Kyoto mutation of the APOE gene. These findings are consistent with the diagnosis of lipoprotein glomerulopathy. Prednisone was gradually tapered and captopril was initiated. A 2-year follow-up revealed elevated urine protein and serum creatinine levels. We also reviewed 17 pediatric and 156 adult cases of lipoprotein glomerulopathy reported in China from the year of creation to 2021. The most common clinical features were edema, hematuria, hypertriglyceridemia, and increased serum apoE levels. Extra-renal manifestations included anemia, splenomegaly, and cardiac lipoprotein deposition.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> APOE Kyoto is the most common mutation in patients with lipoprotein glomerulopathy. In China, homozygosity for E3 (E3\/3) is the most common isoform.<\/jats:p>","DOI":"10.3389\/fped.2021.684814","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T15:18:31Z","timestamp":1630941511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: A Pediatric Case of Lipoprotein Glomerulopathy in China and Literature Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Yue","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0272-6386(89)80134-9","article-title":"Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia","volume":"13","author":"Saito","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000045511","article-title":"Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants","volume":"83","author":"Saito","year":"1999","journal-title":"Nephron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10157-001-8014-3","article-title":"Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses","volume":"5","author":"Saito","year":"2001","journal-title":"Clin Exp Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10157-009-0207-1","article-title":"Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy","volume":"13","author":"Matsunaga","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3760\/cma.j.issn.1003-9406.2020.02.017","article-title":"Discovery of a Chinese Tibetan patient with lipoprotein glomerulopathy due to APOE Osaka\/Kurashiki variant","volume":"37","author":"Yang","year":"2020","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1281","DOI":"10.1002\/mgg3.1281","article-title":"Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations","volume":"8","author":"Yang","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000168591","article-title":"Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature","volume":"13","author":"Saito","year":"1993","journal-title":"Am J Nephrol"},{"key":"B9","first-page":"112","article-title":"Lipoprotein glomerulopathy","author":"Saito","year":"2007","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2369-14-53","article-title":"A case of lipoprotein glomerulopathy with thrombotic microangiopathy due to malignant hypertension","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/ndt\/gfm735","article-title":"A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy","volume":"23","author":"Hagiwara","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"B12","first-page":"57","article-title":"A rare cause of nephrotic syndrome: lipoprotein glomerulopathy","volume":"15","author":"Cheung","year":"2009","journal-title":"Hong Kong Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.carpath.2019.04.006","article-title":"Intravascular cardiac lipoproteinosis: extrarenal manifestation of lipoprotein glomerulopathy","volume":"42","author":"Morris","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1590\/2175-8239-jbn-2018-0148","article-title":"Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: a review","volume":"41","author":"Cambruzzi","year":"2019","journal-title":"J Bras Nefrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1194\/jlr.M088732","article-title":"Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy","volume":"59","author":"Katsarou","year":"2018","journal-title":"J Lipid Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.5551\/jat.41996","article-title":"The novel apolipoprotein E mutation ApoE Chengdu (c.518T>C, p.L173P) in a Chinese patient with lipoprotein glomerulopathy","volume":"25","author":"Wu","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"B17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000111828","article-title":"Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy","volume":"28","author":"Luo","year":"2008","journal-title":"Am J Nephrol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/CM9.0000000000000050","article-title":"A novel apolipoprotein E mutation (p.Arg150Cys) in a Chinese patient with lipoprotein glomerulopathy","volume":"132","author":"Ku","year":"2019","journal-title":"Chin Med J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5414\/CN106876","article-title":"A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy","volume":"78","author":"Liao","year":"2012","journal-title":"Clin Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1046\/j.1523-1755.1999.00677.x","article-title":"A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy","volume":"56","author":"Ando","year":"1999","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s004670050032","article-title":"A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy","volume":"14","author":"Ogawa","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMc072088","article-title":"APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy","volume":"357","author":"Rovin","year":"2007","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000355810","article-title":"Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with lipoprotein glomerulopathy","volume":"39","author":"Li","year":"2014","journal-title":"Kidney Blood Press Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/01.LAB.0000022222.03120.D4","article-title":"Renal injury in apolipoprotein E-deficient mice","volume":"82","author":"Wen","year":"2002","journal-title":"Lab Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ki.2013.335","article-title":"Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation","volume":"85","author":"Hu","year":"2014","journal-title":"Kidney Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacl.2018.12.004","article-title":"A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy","volume":"13","author":"Lui","year":"2019","journal-title":"J Clin Lipidol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0272-6386(12)81066-3","article-title":"Lipoprotein glomerulopathy: first report in a Chinese male","volume":"24","author":"Zhang","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/ndt\/gfn555","article-title":"Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study","volume":"24","author":"Xin","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/ckj\/sfu058","article-title":"Long-term outcome of kidney transplantation in a patient with coexisting lipoprotein glomerulopathy and fibrillary glomerulonephritis","volume":"7","author":"Cheung","year":"2014","journal-title":"Clin Kidney J"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.684814\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T15:18:37Z","timestamp":1630941517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.684814\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":29,"alternative-id":["10.3389\/fped.2021.684814"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.684814","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]},"article-number":"684814"}}